Prof. Eyal Shwartzberg

Prof. Eyal Shwartzberg Profile

Associate Professor
Adjunct Assoc. Prof., College of Pharmacy, LIU

Department : School of Pharmacy
Room :
Phone :
Email : eyalsh@bgu.ac.il
Office Hours :  
Clinical Pharmacy, Medication adherence, Digital Health, Regulatory Pathways

Education

  • Ph.D. – 2010, Faculty of Health Sciences, Department of Health Systems Management, Institution: Ben-Gurion University of the Negev, Beer Sheva, Israel. Supevisors: Professor Zvi Ben Zvi, Dr. Segev Shani. Title: Organizational Change in Health Systems – Exploring the Implementation of Clinical Pharmacy Services in Health Organization in Israel – Concept and application.
  • M.Sc. Evidence Based Pharmacotherapy – 2001, School of Pharmacy, Aston University, Birmingham UK. Advisor: Professor Li Wan Po. Title: Intravenous, Crystalloids Fluids Administration in the Surgical Ward – An Evidence Based Prospective Audit.
  • Medicine, University of Wales, Cardiff, Wales, UK
  •  BPharm (Hons) – 1996, School of Pharmacy, University of Wales, UK

Research Interests

  • Patients' Medication Adherence
  • Developing Clinical Pharmacy Tools
  • Digital tools for Patients empowerment
  • Innovative adaptive regulatory pathways

Publications and funding summary / representative publications and grants

  •  Schwartzberg E, Nathan JP, Avron S, Marom E (2018) Clinical and other specialty services offered by pharmacists in the community: the international arena and Israel. Israel Journal of Health Policy Research. 7(1):59. doi: 10.1186/s13584-018-0251-y.
  •  E Schwartzberg, JP Nathan, Marom E, B Rosen (2018) Pharmacy in Israel. American Journal of Health-System Pharmacy. 75:1(E57-E61)
  • E Schwartzberg, Z Barnett-Itzhaki, I Grotto, E Marom (2017) Strategies for patient empowerment through the promotion of medicines in Israel: regulatory framework for the pharmaceutical industry. Israeli Journal of Health Policy Research
  • Schwartzberg E. Chapter 13 - Building quality into decision making through a structured approach to the benefit-risk assessment of medicines within a developing agency: Israel ministry of health perspective 173. S Walker S, N McAuslane, M Bujar, P Connelly P, L Liberti, eds. Quality decision-making practices: Their application and impact in the development, review and reimbursement of medicines: Tysons Corner, Virginia, US: ©Centre for Innovation in Regulatory Science; 2017. ISBN: 978-94-6182-866-8

 

Existing collaborations

  • Professor Nathan Joseph Pesach, Arnold & Marie Schwartz College of Pharmacy, Brooklyn Campus, LIU, US
  • Israeli National Digital Leaders Network
  • 8400 Health Network